Skip to main content
OpenTrials

Clinical trial condition

Metastatic Head and Neck Squamous Cell Carcinoma

Explore clinical trials studying Metastatic Head and Neck Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.

28 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Head and Neck Squamous Cell Carcinoma trial results

Recruiting

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

NCT05136196

Conditions
Carcinoma, Carcinoma, Squamous Cell, Clinical Stage III Cutaneous Melanoma AJCC v8, +52 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
View all 225 locations
View Trial Details
Recruiting

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

NCT06589804

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +38 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Fremont - Rideout Cancer Center Marysville, California, United States
  • VA Palo Alto Health Care System Palo Alto, California, United States
  • UCHealth Memorial Hospital Central Colorado Springs, Colorado, United States
View all 192 locations
View Trial Details
Recruiting

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

NCT06788990

Conditions
Bone Diseases, Bone Diseases, Developmental, Camurati-Engelmann Syndrome, +17 more
Locations
  • Site # 0137 Birmingham, Alabama, United States
  • Site #0147 Phoenix, Arizona, United States
  • Site #0107 La Jolla, California, United States
  • Site #0106 Los Angeles, California, United States
View all 203 locations
View Trial Details
Recruiting

Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma

NCT06211335

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +8 more
Locations
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • University of Colorado Denver | Anschutz Medical Campus Aurora, Colorado, United States
View Trial Details

Related conditions